| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 01/17/2013 | US20130018481 Coated stents and process for coating with protein |
| 01/17/2013 | US20130018299 Nanoshells on polymers |
| 01/17/2013 | US20130018100 Tranexamic Acid Formulations |
| 01/17/2013 | US20130018084 MICRORNA (miRNA) AND DOWNSTREAM TARGETS FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES |
| 01/17/2013 | US20130018071 Solid Forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 01/17/2013 | US20130018057 Quinoline and Quinoxaline Derivatives as Kinase Inhibitors |
| 01/17/2013 | US20130018053 Substituted pyrimidines |
| 01/17/2013 | US20130018052 2-pyridyl substituted imidazoles as alk5 and/or alk4 inhibitors |
| 01/17/2013 | US20130018041 Pyrimidine-2-amine compounds and their use as inhibitors of jak kinases |
| 01/17/2013 | US20130018022 Pharmaceutical composition including a testis extract as an active ingredient for treating and preventing anemia |
| 01/17/2013 | US20130018014 New class of therapeutics that enhance small molecule diffusion |
| 01/17/2013 | US20130018005 Glycoside derivatives and uses thereof |
| 01/17/2013 | US20130017998 Novel modified galectin 9 proteins and use thereof |
| 01/17/2013 | US20130017997 Factor VIII Compositions and Methods of Making and Using Same |
| 01/17/2013 | US20130017996 Muteins of tear lipocalin and methods for obtaining the same |
| 01/17/2013 | US20130017995 Modified animal erythropoietin polypeptides and their uses |
| 01/17/2013 | US20130017565 Methods and products related to low molecular weight heparin |
| 01/17/2013 | US20130017262 Immediate/delayed drug delivery |
| 01/17/2013 | US20130017255 Tamper Resistant Dosage Form Comprising an Adsorbent and an Adverse Agent |
| 01/17/2013 | US20130017227 Wound healing compositions and associated methods |
| 01/17/2013 | US20130017226 TNF-A and TWEAK Dual Antagonist for the Prophylaxis and Treatment of Autoimmune Diseases |
| 01/17/2013 | US20130017197 Stabilized antibody preparations and uses thereof |
| 01/17/2013 | US20130017189 Functionalised Triblock Copolymers and Compositions Containing Such Polymers |
| 01/17/2013 | US20130017184 Stabilised solid compositions of factor VII polypeptides |
| 01/17/2013 | US20130017172 Sensitization of Chemotherapeutic Agent Resistant Neoplastic Cells With a Virus |
| 01/17/2013 | CA2841066A1 Factor viii chimeric and hybrid polypeptides, and methods of use thereof |
| 01/16/2013 | EP2546253A1 Substituted dihydropyrazolones for the treatment of cardiovascular and hematological diseases |
| 01/16/2013 | EP2545917A1 Novel ep4 agonist |
| 01/16/2013 | EP2544706A1 Modulating aquaporins with relaxin |
| 01/16/2013 | CN1495197B G-CSF analogs composition and its preparation method |
| 01/16/2013 | CN1454257B Production of recombinant blood clotting factors in human cell lines |
| 01/16/2013 | CN102884053A Cyclopropanecarboxylic acid derivative |
| 01/16/2013 | CN102884047A 2-pyridone compounds |
| 01/16/2013 | CN102883742A Modulating aquaporins with relaxin |
| 01/16/2013 | CN102875679A Anti-platelet membrane glycoprotein vi monoclonal antibody |
| 01/16/2013 | CN102875644A GRPAK/tetrahydroglyoxaline/RGD ternary conjugate as well as preparation method and application thereof |
| 01/16/2013 | CN102875533A Dabigatran derivative, preparation method of dabigatran derivative and anti-thrombus application |
| 01/16/2013 | CN102875529A Dabigatran derivatives and preparation method thereof |
| 01/16/2013 | CN102872451A Liquid composition of factor vii polypeptides |
| 01/16/2013 | CN102872448A Preparation of recombinant sophora lopecuraides agglutinin and application thereof |
| 01/16/2013 | CN102872446A Method for preparing anti-thrombosis and thrombolysis oral liquid |
| 01/16/2013 | CN102872434A Preparation method for Chinese angelica mutton medicine |
| 01/16/2013 | CN102872405A Medicament for treating jaundice and preparation method thereof |
| 01/16/2013 | CN102872379A Lotus leaf and atractylodes rhizome soup and preparing method thereof |
| 01/16/2013 | CN102872378A Lotus leaf slimming soup and preparation method thereof |
| 01/16/2013 | CN102872365A Traditional Chinese medicine for treating anaemia |
| 01/16/2013 | CN102872363A Chinese medicinal oral liquid for treating anemia |
| 01/16/2013 | CN102872336A Traditional Chinese medicine for treating multiple myeloma |
| 01/16/2013 | CN102872332A Bao yaowang medicinal and edible Chinese medicinal herb composition for treating blood diseases and preparation method and application thereof |
| 01/16/2013 | CN102872329A Traditional Chinese medicine granule for treating spleen-stomach deficiency type children's nutritional anemia |
| 01/16/2013 | CN102872295A New process for preparing cinnamon, Radix aconiti lateralis preparata and rehmannia root preparation |
| 01/16/2013 | CN102872265A American ginseng and fleece-flower root humagsolan tablet group |
| 01/16/2013 | CN102872257A Chinese angelica and rehmannia blood-enriching tablets |
| 01/16/2013 | CN102872254A Granules for activating blood and removing stasis |
| 01/16/2013 | CN102872249A Ventricular hemorrhage health care product containing compound Chinese medicine tincture and a preparation method for ventricular hemorrhage health care product |
| 01/16/2013 | CN102872242A Chinese medicine for treating urinary obstruction of old people |
| 01/16/2013 | CN102872239A Qi-tonifying and yang-raising tablets |
| 01/16/2013 | CN102872223A Health protection medicine for enriching blood and prolonging life |
| 01/16/2013 | CN102872219A Medicine composition with effects of clearing heat, purging fire, removing toxin, removing stasis, cooling blood, and stopping bleeding and preparation method thereof |
| 01/16/2013 | CN102872211A Chinese medicine for treating epistaxis and preparation method thereof |
| 01/16/2013 | CN102872203A Technology for synchronously producing total flavone, total alkaloid and total polysaccharide in mulberry bark |
| 01/16/2013 | CN102872186A Production method of compound ferrous sulfate and folic acid tablets |
| 01/16/2013 | CN102872185A Method for ultrasonically extracting coumarin from alfalfa |
| 01/16/2013 | CN102872047A Application of Gypensapogenin A in medicament for increasing level of blood platelets |
| 01/16/2013 | CN102872043A Application of Gypensapogenin B in medicament of increasing level of leukocyte |
| 01/16/2013 | CN102872040A Application of Gypensapogenin B in medicament for increasing level of blood platelets |
| 01/16/2013 | CN102872036A Application of Gypensapogenin A in medicament for increasing level of red blood cells |
| 01/16/2013 | CN102872035A Application of Gypensapogenin A in medicaments against platelet aggregation |
| 01/16/2013 | CN102872020A Inhibitor of pai-1 production |
| 01/16/2013 | CN102872015A Stephanotis total alkaloid extract as well as preparation method and application thereof |
| 01/16/2013 | CN102871991A Application of dimethyldiguanide in drugs taking protective effect on chemoradiotherapy injury |
| 01/16/2013 | CN102871985A Hemoglobin microcapsule blood substitute and its preparation method |
| 01/16/2013 | CN102871961A Injection containing tirofiban |
| 01/16/2013 | CN102871897A Peppermint tooth care mouth wash |
| 01/16/2013 | CN102871854A Toothpaste for preventing gum bleeding |
| 01/16/2013 | CN102871071A Ginger powder and processing method thereof |
| 01/16/2013 | CN102283951B Chinese medicinal composition for treating anaphylactoid purpura and thrombocytopenic purpura |
| 01/16/2013 | CN101904893B Angelica sinensis blood enriching capsule and preparation method thereof |
| 01/15/2013 | US8354397 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 01/15/2013 | CA2427774C Inhibitors of thromboxane formation and action |
| 01/15/2013 | CA2406725C Edg8 receptor, its preparation and use |
| 01/10/2013 | WO2013004845A1 Cyclic tripeptide mimetics as plasmin inhibitors |
| 01/10/2013 | WO2013003947A1 Iron supplement composition |
| 01/10/2013 | WO2012156537A3 Lysine demethylase inhibitors such as cyclylcylopropamine derivatives for use in the treatment of thrombosis and cardiovascular diseases |
| 01/10/2013 | WO2012156531A3 Lysine demethylase inhibitors such as cyclylcylopropamine derivatives for use in the treatment of inflammatory diseases or conditions |
| 01/10/2013 | WO2012151575A3 A method of controlling coagulation |
| 01/10/2013 | US20130012708 Heterocyclic compounds and thrombopoietin receptor activators |
| 01/10/2013 | US20130012692 Sodium channel blockers |
| 01/10/2013 | US20130012603 Methods for assessing the risk of cardiovascular disease |
| 01/10/2013 | US20130012583 Vinyl substituted fatty acids |
| 01/10/2013 | US20130012574 Compositions and Methods for Enhanced Parvovirus Transduction |
| 01/10/2013 | US20130012536 Modulators of atp-binding cassette transporters |
| 01/10/2013 | US20130012535 Sustained-release solid preparation for oral use |
| 01/10/2013 | US20130012534 Pharmaceutical Compositions Comprising Prasugrel and Cyclodextrin Derivatives and Methods of Making and Using the Same |
| 01/10/2013 | US20130012532 Cyclopropanecarboxylic acid derivative |
| 01/10/2013 | US20130012517 Quinoline and Quinoxaline Derivatives as Kinase Inhibitors |
| 01/10/2013 | US20130012511 Soluble guanylate cyclase activators |
| 01/10/2013 | US20130012479 Polymorphs of 6-(piperidin-4-yloxy)-2h-isoquinolin-1-one hydrochloride |
| 01/10/2013 | US20130012443 Methods of treatment of central nervous system hemorrhage using protoporphyrin ix-fe compounds |
| 01/10/2013 | US20130012442 Von willebrand factor- and factor viii-polymer conjugates having a releasable linkage |